{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:12:57Z","timestamp":1792141977547,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.nmd.2023.12.008","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T22:40:00Z","timestamp":1702507200000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10\u201312 March, 2023, Hoofddorp, the Netherlands"],"prefix":"10.1016","volume":"34","author":[{"given":"Emanuela","family":"Abiusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Costa-Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Silvio","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Danilo","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo F.","family":"Tizzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Emanuela","family":"Abiusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Giovanni","family":"Baranello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Fran\u00e7ois","family":"Boemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Arthur","family":"Burghes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Marta","family":"Codina-Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Mar","family":"Costa-Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Tamara","family":"Dangouloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Ewout","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Monika","family":"Gos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Maria","family":"J\u0119drzejowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Henny H","family":"Lemmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Wolfgang","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ms Marie-Christine","family":"Ouillade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Susana","family":"Quijano-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mr Kacper","family":"Rucinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Pascale","family":"Saugier-Veber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Francesco Danilo","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Eduardo Fidel","family":"Tizzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof. Brunhilde","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.nmd.2023.12.008_bib0002","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2353\/ajpath.2007.070399","article-title":"Refined characterization of the expression and stability of the SMN gene products","volume":"171","author":"Vitte","year":"2007","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0003","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.nmd.2023.12.008_bib0004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.nmd.2023.12.008_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa075","article-title":"Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy","volume":"2","author":"Wadman","year":"2020","journal-title":"Brain Commun"},{"issue":"6","key":"10.1016\/j.nmd.2023.12.008_bib0007","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/humu.24200","article-title":"Beyond copy number: a new, rapid, and versatile method for sequencing the entire SMN2 gene in SMA patients","volume":"42","author":"Blasco-P\u00e9rez","year":"2021","journal-title":"Hum Mutat"},{"issue":"16","key":"10.1016\/j.nmd.2023.12.008_bib0008","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.3390\/ijms22169029","article-title":"The Importance of digging into the genetics of SMN genes in the therapeutic scenario of spinal muscular atrophy","volume":"22","author":"Costa-Roger","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(94)00075-K","article-title":"Chaos in the classification of SMA: a possible resolution","volume":"5","author":"Dubowitz","year":"1995","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2023.12.008_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation","volume":"7","author":"Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.nmd.2023.12.008_bib0012","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy - insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.nmd.2023.12.008_bib0014","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/genes14071377","article-title":"Spinal muscular atrophy treatment in patients identified by newborn screening-a systematic review","volume":"14","author":"Aragon-Gawinska","year":"2023","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nmd.2019.11.002","article-title":"NBS SMA Study Group. 244th ENMC international workshop: newborn screening in spinal muscular atrophy May 10-12, 2019, Hoofdorp, The Netherlands","volume":"30","author":"Dangouloff","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.12.008_bib0016","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","article-title":"Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go","volume":"31","author":"Dangouloff","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.12.008_bib0017","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.0000000000007836","article-title":"Discrepancy in redetermination of SMN2 copy numbers in children with SMA","volume":"93","author":"Schorling","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nmd.2023.12.008_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JND-220789","article-title":"Spinal muscular atrophy - is newborn screening too late for children with two SMN2 copies?","volume":"9","author":"Schwartz","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.12.008_bib0019","unstructured":"Vr\u0161\u010daj E, Dangouloff T, Osredkar D, Servais L. Newborn screening programs for spinal muscular atrophy worldwide: second edition. Eur J Paediatr Neurol. In press."},{"key":"10.1016\/j.nmd.2023.12.008_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/JND-221577","article-title":"Newborn screening SMA - from pilot project to nationwide screening in Germany","volume":"10","author":"M\u00fcller-Felber","year":"2023","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijns5020021","article-title":"Validation of a fast, robust, inexpensive, two-tiered neonatal screening test algorithm on dried blood spots for spinal muscular atrophy","volume":"5","author":"Strunk","year":"2019","journal-title":"Int J Neonatal Screen"},{"issue":"7","key":"10.1016\/j.nmd.2023.12.008_bib0022","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jmg-2022-108873","article-title":"Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis","volume":"60","author":"Abiusi","year":"2023","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.nmd.2023.12.008_bib0023","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00431-022-04470-3","article-title":"Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening","volume":"181","author":"Pane","year":"2022","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.nmd.2023.12.008_bib0024","doi-asserted-by":"crossref","first-page":"E1110","DOI":"10.1002\/humu.21173","article-title":"A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy","volume":"31","author":"Vezain","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2023.12.008_bib0025","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/ddx166","article-title":"A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy","volume":"26","author":"Wu","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.nmd.2023.12.008_bib0026","first-page":"461","article-title":"(S)un (M)ay (A)rise on SMA: the hope of a region without spinal muscular atrophy","volume":"74","author":"Boemer","year":"2019","journal-title":"Rev Med Liege"},{"issue":"5","key":"10.1016\/j.nmd.2023.12.008_bib0027","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nmd.2019.02.003","article-title":"Newborn screening for SMA in Southern Belgium","volume":"29","author":"Boemer","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0028","doi-asserted-by":"crossref","first-page":"19922","DOI":"10.1038\/s41598-021-99496-2","article-title":"Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium","volume":"11","author":"Boemer","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2023.12.008_bib0029","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13023-019-1125-2","article-title":"De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany","volume":"14","author":"K\u00f6nig","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2023.12.008_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/children9121829","article-title":"Parental burden and quality of life in 5q-SMA diagnosed by newborn screening","volume":"9","author":"K\u00f6lbel","year":"2022","journal-title":"Children"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0031","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/brain\/awac252","article-title":"Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy","volume":"146","author":"Pechmann","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0033","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13023-022-02547-8","article-title":"Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study","volume":"17","author":"Pechmann","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0034","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JND-221600","article-title":"Improvements in walking distance during nusinersen treatment \u2013 a prospective 3-year SMArtCARE registry study","volume":"10","author":"Pechmann","year":"2023","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12891-015-0457-x","article-title":"Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls","volume":"16","author":"Fang","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"10.1016\/j.nmd.2023.12.008_bib0036","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ejhg.5201032","article-title":"Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1","volume":"11","author":"Ogino","year":"2003","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.nmd.2023.12.008_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220211","article-title":"The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent","volume":"14","author":"Vijzelaar","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0038","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.braindev.2020.09.005","article-title":"Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene","volume":"43","author":"Niba","year":"2021","journal-title":"Brain Dev"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0039","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.nmd.2023.12.008_bib0040","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1212\/NXG.0000000000000530","article-title":"Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy","volume":"6","author":"Cusc\u00f3","year":"2020","journal-title":"Neurol Genet"},{"issue":"15","key":"10.1016\/j.nmd.2023.12.008_bib0041","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.3390\/ijms23158289","article-title":"Deep molecular characterization of milder spinal muscular atrophy patients carrying the c.859G>C variant in SMN2","volume":"23","author":"Blasco-P\u00e9rez","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6588","key":"10.1016\/j.nmd.2023.12.008_bib0042","doi-asserted-by":"crossref","first-page":"eabj6965","DOI":"10.1126\/science.abj6965","article-title":"Segmental duplications and their variation in a complete human genome","volume":"376","author":"Vollger","year":"2022","journal-title":"Science"},{"issue":"6588","key":"10.1016\/j.nmd.2023.12.008_bib0043","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.abj6987","article-title":"The complete sequence of a human genome","volume":"376","author":"Nurk","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.nmd.2023.12.008_bib0044","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00439-019-01983-0","article-title":"Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype","volume":"138","author":"Ruhno","year":"2019","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JND-190399","article-title":"Spinal Muscular Atrophy (SMA) subtype concordance in siblings: findings from the cure SMA cohort","volume":"7","author":"Jones","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.12.008_bib0046","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","article-title":"Evidence for modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1","volume":"114","author":"Helmken","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.nmd.2023.12.008_bib0047","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.nmd.2023.12.008_bib0048","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ejhg.2008.41","article-title":"Unaffected patients with a homozygous absence of the SMN1 gene","volume":"16","author":"J\u0119drzejowska","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.nmd.2023.12.008_bib0049","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nmd.2011.03.009","article-title":"Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings","volume":"21","author":"Bernal","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.12.008_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2","volume":"130A","author":"Prior","year":"2004","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.nmd.2023.12.008_bib0051","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/hmg\/5.3.359","article-title":"Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy","volume":"5","author":"Wang","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017067","article-title":"Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study","volume":"6","author":"Su","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0053","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.nmd.2023.12.008_bib0054","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.nmd.2017.06.559","article-title":"Longitudinal assessments in discordant twins with SMA","volume":"27","author":"Pane","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","article-title":"Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis","volume":"100","author":"Riessland","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"13","key":"10.1016\/j.nmd.2023.12.008_bib0056","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1007\/s00018-021-03843-5","article-title":"Plastin 3 in health and disease: a matter of balance","volume":"78","author":"Wolff","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.nmd.2023.12.008_bib0057","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ajhg.2023.02.004","article-title":"Epigenetic regulation of plastin 3 expression by the macrosatellite DXZ4 and the transcriptional regulator CHD4","volume":"110","author":"Strathmann","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.nmd.2023.12.008_bib0058","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.3390\/ijms24044198","article-title":"Long-term SMN- and Ncald-ASO combinatorial therapy in SMA Mice and NCALD-ASO treatment in hiPSC-derived motor neurons show protective effects","volume":"24","author":"Mui\u00f1os-B\u00fchl","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.nmd.2023.12.008_bib0059","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/jmedgenet-2018-105482","article-title":"Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol","volume":"56","author":"Tiziano","year":"2019","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.nmd.2023.12.008_bib0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.nmd.2023.12.008_bib0061","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/acn3.51449","article-title":"Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children","volume":"8","author":"Nitz","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2023.12.008_bib0062","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.omtm.2021.10.011","article-title":"Implications of circulating neurofilaments for spinal muscular atrophy treatment early in life: a case series","volume":"23","author":"Alves","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.nmd.2023.12.008_bib0063","doi-asserted-by":"crossref","first-page":"e68054","DOI":"10.7554\/eLife.68054","article-title":"SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples","volume":"10","author":"Abiusi","year":"2021","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.nmd.2023.12.008_bib0064","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/acn3.51579","article-title":"Response of plasma microRNAs to nusinersen treatment in patients with SMA","volume":"9","author":"Zaharieva","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0065","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/pharmaceutics15010170","article-title":"Identification of novel CSF-derived miRNAs in treated paediatric onset spinal muscular atrophy: an exploratory study","volume":"15","author":"D'Silva","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.nmd.2023.12.008_bib0066","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/ene.15382","article-title":"Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients","volume":"29","author":"Magen","year":"2022","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0067","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00415-022-11326-1","article-title":"MRI correlates of motoneuron loss in SMA","volume":"270","author":"Sprenger-Sva\u010dina","year":"2023","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2023.12.008_bib0068","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1212\/WNL.0000000000008762","article-title":"Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy","volume":"94","author":"Alves","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2023.12.008_bib0069","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/acn3.51340","article-title":"Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment","volume":"8","author":"Freigang","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2023.12.008_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.nmd.2023.12.008_bib0071","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ejhg.2009.116","article-title":"SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR","volume":"18","author":"Tiziano","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.nmd.2023.12.008_bib0072","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/gtmb.2019.0282","article-title":"Incorporating spinal muscular atrophy analysis by next-generation sequencing into a comprehensive multigene panel for neuromuscular disorders","volume":"24","author":"Tan","year":"2020","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"10.1016\/j.nmd.2023.12.008_bib0073","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/ijns7030047","article-title":"Novel modification of a confirmatory SMA sequencing assay that can be used to determine SMN2 copy number","volume":"7","author":"Kumar","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.nmd.2023.12.008_bib0074","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cca.2022.05.017","article-title":"Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing","volume":"532","author":"Jin","year":"2022","journal-title":"Clin Chim Acta"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623008398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623008398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:15:16Z","timestamp":1760775316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623008398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":73,"alternative-id":["S0960896623008398"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.12.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10\u201312 March, 2023, Hoofddorp, the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}